Erratum to “DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway”

In the article titled “DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway” [1], there was an error in Figure2, where the Western blots in Figures2(b)and2(c)were duplicated, due to a production error. The correct figure is as follows.

(a)

(b)

(c)

(a)
(b)
(c)

Figure 2

Expression of DAB2IP in human gastric cancer cells and the knockdown efficiency of DAB2IP. (a) DAB2IP protein and mRNA expression in four gastric cancer cell lines were detected by Western blot and QRT-PCR. The bar graphs represent the 18 s-normalized DAB2IP mRNA levels. Error bars represent SEM ( ).(b, c) The protein and mRNA levels of DAB2IP expression in wild-type cells (shControl) and in cells with stable knockdown of DAB2IP (shDAB2IP) were tested by Western blot and QRT-PCR in (b) AGS and (c) SGC7901 gastric cancer cells. Error bars represent SEM ( ).Statistical significance was determined by a two-tailed, unpaired Student’s -test. .

References

1. L. Sun, Y. Yao, T. Lu et al., “DAB2IP downregulation enhances the proliferation and metastasis of human gastric cancer cells by derepressing the ERK1/2 pathway,”胃肠病学研究和Practice, vol. 2018, Article ID 2968252, 10 pages, 2018.View at:Publisher Site|Google Scholar

Copyright

Copyright © 2020 Liang Sun et al. This is an open access article distributed under theCreative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.